First human test: how kidneys handle a powerful new antibiotic
NCT ID NCT06672276
Summary
This early-stage study aimed to understand how a new antibiotic combination (TQD3606) is processed by the body in people with varying levels of kidney function. It enrolled 32 adults, comparing those with healthy kidneys to those with mild, moderate, or severe kidney disease. The main goal was to measure drug levels in the blood and urine and check for safety, not to treat an infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESISTANT TO GRAM-POSITIVE, GRAM-NEGATIVE AND ANAEROBIC BACTERIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)
Jinan, Shandong, 250014, China
-
The Second Hospital of Shandong University
Jinan, Shandong, 250014, China
Conditions
Explore the condition pages connected to this study.